Home LiteratureArticle Details
PMID: 1541544 Published · ppublish English Journal Article Review

Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Infection and immunity ·Vol. 60 ·No. 3 ·1992-03-00 ·Pages 721-7

Horstmann RD

Abstract

暂无摘要

MeSH Terms
Animals Bacterial Infections/immunology Complement Pathway, Alternative Humans Immunity, Innate Infections/immunology Mycoses/immunology Parasitic Diseases/immunology Virus Diseases/immunology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Horstmann R D
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
References (97)
97 references, click to expand
  1. Babesia rodhaini interactions with complement: relationship to parasitic entry into red cells.
    J Immunol. 1980 Apr;124(4):1566-73 PMID: 6767771
  2. Molecular basis for trypanosome antigenic variation.
    Cell. 1982 Jun;29(2):291-303 PMID: 6811137
  3. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):5118-21 PMID: 6946459
  4. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    J Immunol. 1982 Mar;128(3):1278-83 PMID: 7035562
  5. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    J Immunol. 1980 May;124(5):2502-6 PMID: 7365262
  6. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.
    J Exp Med. 1987 Jan 1;165(1):195-210 PMID: 3025331
  7. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.
    Nature. 1988 Sep 1;335(6185):79-82 PMID: 3045563
  8. Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding.
    Proc Natl Acad Sci U S A. 1986 Jan;83(1):100-4 PMID: 3079902
  9. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
    Infect Immun. 1987 Jan;55(1):174-80 PMID: 3098684
  10. Species specificity of recognition by the alternative pathway of complement.
    J Immunol. 1985 Feb;134(2):1101-4 PMID: 3155536
  11. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
    J Immunol. 1985 Oct;135(4):2785-9 PMID: 3161950
  12. Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes.
    Mol Biochem Parasitol. 1988 Jan 1;27(1):43-52 PMID: 3278222
  13. Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii.
    Infect Immun. 1987 Sep;55(9):2066-73 PMID: 3305362
  14. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.
    J Immunol. 1988 Mar 1;140(5):1588-94 PMID: 3346543
  15. Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense.
    Infect Immun. 1986 Apr;52(1):223-9 PMID: 3633873
  16. Complement-mediated killing of Opisthorchis viverrini via activation of the alternative pathway.
    Int J Parasitol. 1986 Aug;16(4):341-6 PMID: 3744673
  17. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate.
    EMBO J. 1985 Feb;4(2):329-36 PMID: 4018028
  18. Serum-dependent adhesion and cytotoxicity of cells to Litomosoides carinii microfilariae.
    Nature. 1976 Apr 8;260(5551):529-30 PMID: 944376
  19. Decay-accelerating factor and membrane cofactor protein.
    Curr Top Microbiol Immunol. 1990;153:123-45 PMID: 1688754
  20. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor.
    J Immunol. 1990 Apr 1;144(7):2751-6 PMID: 1690776
  21. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6 PMID: 1692629
  22. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.
    J Bacteriol. 1991 May;173(9):2823-32 PMID: 1708379
  23. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins.
    J Immunol. 1990 Jun 15;144(12):4817-24 PMID: 1972169
  24. Eosinophil-larval-interaction in onchocerciasis: heterogeneity of in vitro adherence of eosinophils to infective third and fourth stage larvae and microfilariae of Onchocerca volvulus.
    Parasite Immunol. 1991 Jan;13(1):13-22 PMID: 2014134
  25. Strategies of obligate intracellular parasites for evading host defences.
    Immunol Today. 1991 Mar;12(3):A22-7 PMID: 2069674
  26. Factor H.
    Curr Top Microbiol Immunol. 1990;153:147-62 PMID: 2137073
  27. Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.
    Infect Immun. 1990 Nov;58(11):3508-15 PMID: 2228221
  28. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.
    J Clin Invest. 1990 Dec;86(6):1815-22 PMID: 2254446
  29. Demonstration of C3b receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes.
    Eur J Immunol. 1986 Sep;16(9):1069-73 PMID: 2428623
  30. Two variant surface glycoproteins of Trypanosoma brucei of different sequence classes have similar 6 A resolution X-ray structures.
    Nature. 1987 Jan 1-7;325(6099):84-6 PMID: 2432433
  31. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    J Immunol. 1987 Aug 15;139(4):1253-9 PMID: 2440949
  32. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).
    Cell. 1989 Feb 10;56(3):369-77 PMID: 2464439
  33. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages.
    J Immunol. 1989 Jul 15;143(2):617-22 PMID: 2525590
  34. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2453-7 PMID: 2538841
  35. Complement receptors: another port of entry for HIV.
    Lancet. 1989 Jul 29;2(8657):271-2 PMID: 2569072
  36. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    J Immunol. 1989 Dec 1;143(11):3743-9 PMID: 2584716
  37. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
    J Immunol. 1989 Feb 1;142(3):940-7 PMID: 2643665
  38. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.
    Infect Immun. 1989 Aug;57(8):2372-7 PMID: 2663722
  39. Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages.
    J Biol Chem. 1989 May 5;264(13):7483-9 PMID: 2708373
  40. Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.
    Infect Immun. 1989 Dec;57(12):3869-75 PMID: 2807551
  41. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
    J Exp Med. 1987 Nov 1;166(5):1525-35 PMID: 2824652
  42. Epstein-Barr virus regulates activation and processing of the third component of complement.
    J Exp Med. 1988 Sep 1;168(3):949-69 PMID: 2844953
  43. Activation of the alternative complement pathway in normal human serum by Loa loa and Brugia malayi infective stage larvae.
    Acta Trop. 1985 Jun;42(2):157-63 PMID: 2862778
  44. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
    J Immunol. 1986 Mar 15;136(6):2265-70 PMID: 2869084
  45. Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.
    Immunology. 1986 Jul;58(3):467-71 PMID: 2874111
  46. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.
    Infect Immun. 1985 Nov;50(2):598-600 PMID: 2932390
  47. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
    J Immunol. 1986 Dec 1;137(11):3577-83 PMID: 2946764
  48. The superfamily of C3b/C4b-binding proteins.
    Fed Proc. 1987 May 15;46(7):2463-9 PMID: 2952524
  49. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
    Proc Natl Acad Sci U S A. 1988 Mar;85(5):1657-61 PMID: 2964038
  50. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7734-8 PMID: 2971974
  51. Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination.
    Infect Immun. 1985 Jun;48(3):782-6 PMID: 2987130
  52. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    J Immunol. 1986 Sep 1;137(5):1636-41 PMID: 3018078
  53. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major.
    Nature. 1987 May 28-Jun 3;327(6120):329-31 PMID: 3035377
  54. Molecular organization and function of the complement system.
    Annu Rev Biochem. 1988;57:321-47 PMID: 3052276
  55. Complement evasion by bacteria and parasites.
    Annu Rev Microbiol. 1988;42:201-30 PMID: 3059994
  56. Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
    Infect Immun. 1986 Dec;54(3):689-94 PMID: 3096887
  57. Differences in uptake of mycobacteria by human monocytes: a role for complement.
    Infect Immun. 1988 Sep;56(9):2223-7 PMID: 3137162
  58. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.
    J Gen Microbiol. 1988 Dec;134(12):3295-306 PMID: 3151997
  59. Membrane complement receptors specific for bound fragments of C3.
    Adv Immunol. 1985;37:217-67 PMID: 3159188
  60. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
    Proc Natl Acad Sci U S A. 1988 Jan;85(1):193-7 PMID: 3277170
  61. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.
    J Exp Med. 1988 Mar 1;167(3):887-902 PMID: 3280727
  62. Parasites and complement.
    Adv Parasitol. 1988;27:131-68 PMID: 3289328
  63. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors.
    J Exp Med. 1987 Nov 1;166(5):1377-89 PMID: 3316470
  64. The promastigote surface protease of Leishmania.
    Parasitol Today. 1987 May;3(5):151-3 PMID: 15462939
  65. The lipophosphoglycan of Leishmania.
    Parasitol Today. 1988 Sep;4(9):255-7 PMID: 15463118
  66. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma).
    Science. 1948 Dec 10;108(2815):660-3 PMID: 17744024
  67. Complement does not play a role in promoting Babesia rodhaini infections in Balb/C mice.
    Z Parasitenkd. 1982;68(3):249-57 PMID: 6218704
  68. Third component of complement, immunoglobulin deposition, and leucocyte attachment related to surface sulfate on larval Taenia taeniaeformis.
    J Parasitol. 1983 Aug;69(4):637-44 PMID: 6226775
  69. The alternative pathway of complement.
    Springer Semin Immunopathol. 1984;7(2-3):163-92 PMID: 6238433
  70. Complement, viruses, and virus-infected cells.
    Springer Semin Immunopathol. 1983;6(4):327-47 PMID: 6364429
  71. The membrane attack complex.
    Springer Semin Immunopathol. 1984;7(2-3):93-141 PMID: 6387983
  72. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.
    J Immunol. 1984 Apr;132(4):2046-52 PMID: 6699407
  73. Activation of the alternative complement pathway by Trichomonas vaginalis.
    Infect Immun. 1981 Oct;34(1):268-73 PMID: 6795124
  74. Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.
    Infect Immun. 1980 May;28(2):359-67 PMID: 6995306
  75. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.
    J Clin Invest. 1982 Apr;69(4):1042-5 PMID: 7042754
  76. Current knowledge of type-specific M antigens of group A streptococci.
    J Immunol. 1962 Sep;89:307-13 PMID: 14461914
  77. Complement and parasitic trematodes.
    Parasitol Today. 1989 Jan;5(1):19-25 PMID: 15463129
  78. Human serum lyses RNA tumour viruses.
    Nature. 1975 Oct 16;257(5527):612-4 PMID: 170540
  79. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971-5 PMID: 273923
  80. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Infect Immun. 1979 Aug;25(2):603-9 PMID: 385502
  81. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.
    Infect Immun. 1979 Dec;26(3):1159-63 PMID: 393630
  82. Microbial surfaces in relation to pathogenicity.
    Bacteriol Rev. 1977 Jun;41(2):475-500 PMID: 407898
  83. Physicochemical characterization of complement-interacting factors from Taenia taeniaeformis.
    J Immunol. 1978 Mar;120(3):1039-45 PMID: 416142
  84. The cestocidal effect of complement in normal and immuen sera in vitro.
    Parasitology. 1976 Jun;72(3):325-34 PMID: 823517
  85. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
    J Clin Invest. 1988 May;81(5):1434-44 PMID: 3366901
  86. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.
    Eur J Biochem. 1987 Apr 1;164(1):213-21 PMID: 3549304
  87. Complement does not facilitate in vitro invasion of bovine erythrocytes by Babesia bovis.
    Ann Trop Med Parasitol. 1986 Jun;80(3):377-8 PMID: 3643020
  88. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Exp Parasitol. 1986 Dec;62(3):394-404 PMID: 3780933
  89. Serum dependent cell-mediated immune reactions to Brugia pahangi infective larvae.
    Parasite Immunol. 1985 Nov;7(6):633-41 PMID: 4094785
  90. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    J Immunol. 1981 Nov;127(5):1740-3 PMID: 6117595
  91. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    J Immunol. 1983 Jul;131(1):409-15 PMID: 6223077
  92. The human C3b receptor.
    Springer Semin Immunopathol. 1983;6(2-3):159-72 PMID: 6227098
  93. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes.
    J Exp Med. 1983 Dec 1;158(6):2016-23 PMID: 6227677
  94. Regulation of immune response by components of the complement cascade and their activated fragments.
    Springer Semin Immunopathol. 1983;6(2-3):173-94 PMID: 6356429
  95. Complement activation by the surface of Plasmodium falciparum infected erythrocytes.
    Mol Immunol. 1984 Feb;21(2):145-50 PMID: 6369119
  96. Activation of the alternative pathway of complement: efficient fluid-phase amplification by blockade of the regulatory complement protein beta1H through sulfated polyanions.
    Eur J Immunol. 1981 Apr;11(4):291-5 PMID: 6454580
  97. Alternative pathway activation of complement by African trypanosomes lacking a glycoprotein coat.
    Parasite Immunol. 1983 Sep;5(5):491-8 PMID: 6634218
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
DOI
10.1128/iai.60.3.721-727.1992
Published
1992-03-00
Pages
721-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC257545
Subset
IM
External Links
PubMed source DOI: 10.1128/iai.60.3.721-727.1992 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2